Pictet Asset Management (Switzerland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pictet Asset Management (Switzerland)'s BMY Position: Q2 2023 in Review
Pictet Asset Management (Switzerland) reduced its Bristol-Myers Squibb (BMY) stake by 1.5% in Q2 2023, selling an estimated $1.09M and leaving 1,047,007 shares worth $67M. The position accounts for 0.08% of the portfolio, ranked #254.
Pictet Asset Management (Switzerland) first reported a position in BMY in Q3 2021 and has held it in 8 quarters since. The position peaked at $79.7M in Q2 2022. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Pictet Asset Management (Switzerland) held 1,047,007 shares of Bristol-Myers Squibb worth $67M as of Q2 2023.
- Pictet Asset Management (Switzerland) sold 16,325 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.09M.
- Bristol-Myers Squibb made up 0.08% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #254 holding.
- Pictet Asset Management (Switzerland) first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 8 quarters since.
- Pictet Asset Management (Switzerland)'s Bristol-Myers Squibb position peaked at $79.7M in Q2 2022.
- 2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.